Cargando…
Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review
Breast carcinoma is the most frequent and the second leading cause of cancer mortality in women worldwide. Current treatment decisions are based on tumor profiling of the initial tissue biopsy. Cancer though evolves both spatially and temporarily in a significant percentage of patients during treatm...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791253/ https://www.ncbi.nlm.nih.gov/pubmed/33437802 http://dx.doi.org/10.21037/atm-20-1175 |